Advertisement
Screener

Cognition Therapeutics, Inc. (CGTX) Material Contracts

Cognition Therapeutics, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-07: Form 10-Q; Exhibit 10.1; Description First Amendment to Lease Agreement.
  • 2026-05-08: Form 10-Q; Exhibit 10.1; Description Office Lease Agreement between RJ Equities LP and Cognition Therapeutics, Inc., dated July 1, 2017, as amended..
  • 2025-08-28: Form 8-K; Exhibit 10.1; Description Form of Securities Purchase Agreement dated August 27, 2025..
  • 2025-03-20: Form 10-K; Exhibit 10.3; Description Office Lease Agreement between RJ Equities LP and Cognition Therapeutics, Inc., dated July 1, 2017, as amended.
FiledFormExhibitDescription
2026-08-0710-Q10.1First Amendment to Lease Agreement
2026-05-0810-Q10.1Office Lease Agreement between RJ Equities LP and Cognition Therapeutics, Inc., dated July 1, 2017, as amended.
2025-08-288-K10.1Form of Securities Purchase Agreement dated August 27, 2025.
2025-03-2010-K10.3Office Lease Agreement between RJ Equities LP and Cognition Therapeutics, Inc., dated July 1, 2017, as amended
2024-02-208-K10.1Form of Performance Restricted Stock Unit Award Agreement.
2023-05-018-K10.1Employment Agreement, dated April 17, 2023, by and between Cognition Therapeutics, Inc. and John Doyle.
2023-03-108-K10.2Registration Rights Agreement, dated as of March 10, 2023, by and between Cognition Therapeutics, Inc. and Lincoln Park Capital Fund, LLC
2023-03-108-K10.1Purchase Agreement, dated as of March 10, 2023, by and between Cognition Therapeutics, Inc. and Lincoln Park Capital Fund, LLC
2022-12-238-K10.1Controlled Equity OfferingSM Sales Agreement, dated as of December 23, 2022, by and among Cognition Therapeutics, Inc., Cantor Fitzgerald & Co. and B. Riley Securities, Inc.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Vaxart, Inc. (VXRT)United States$0.080B3.84
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41